Tacrolimus ointment: Clinical Trials

22 trials of Tacrolimus ointment, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

17 completed, 4 unknown, 1 terminated. 7 Phase 4, 6 Phase 3, 4 Phase 2, 3 Phase 1, 2 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 47Completed 6, Unknown 1
Phase 36Completed 6
Phase 24Completed 2, Unknown 2
Phase 13Unknown 2, Terminated 1
Not applicable2Completed 2

Follow Tacrolimus ointment: new trials by email Literature Review of Tacrolimus ointment trials Research Report on Tacrolimus ointment

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Clinical Assessment of Protopic® Ointment in Deep Partial-Thickness Burns
Tacrolimus ointment - Burn Injury
Phase 1TerminatedVanderbilt University Medical Center12024-09-192026-07-29
A Comparative Clinical Trial Evaluating the Effect and Safety of Tacrolimus Versus Hydrocortisone
Tacrolimus ointment, Hydrocortisone 1% cream - Dermatologic Disease
Phase 2CompletedTanta University1002022-11-282026-10-30
Efficacy and Safety of 308-nm Excimer Lamp Combined With Tacrolimus vs Tacrolimus as Monotherapy in Treating Vitiligo on Children
exciplex, Tacrolimus ointment - Vitiligo, Pediatric ALL
Not applicableCompletedClarteis502022-10-012023-09-13
Prevention of Breast Cancer-related Lymphedma With Tacrolimus
Tacrolimus ointment - Lymphedema
Phase 1 / Phase 2UnknownOdense University Hospital602020-02-262021-06-25
Tacrolimus for the Treatment of Superficial Kaposiform Hemangioendothelioma and Tufted Angioma
Tacrolimus ointment - Tacrolimus, Kaposiform Hemangioendothelioma, Tufted Angioma
Phase 2UnknownWest China Hospital502019-09-012024-05-07
Uses of Tacrolimus in Behcet Disease
Tacrolimus ointment - Oral Ulcer, Behcet Syndrome
Not applicableCompletedAssiut University402019-04-012021-09-02
Corneal Densitometry Changes With Adenoviral SEI
Tacrolimus ointment, phototherapeutic keratectomy - Corneal Disease
CompletedBenha University632018-04-012020-05-29
The Effect of Fractional Co2 Laser Either With Tacrolimus, Calcipotriol or NB-UVB in Stable Generalized Vitiligo
Tacrolimus ointment, calcipotriol ointment, NB-UVB - Vitiligo Vulgaris
Phase 1UnknownAssiut University302017-08-012017-08-01
Comparison of Efficacy and Safety of 0.1% Tacrolimus and 0.1% Mometasone Furoate for Adult Vitiligo
tacrolimus ointment, Mometasone furoate - Vitiligo
Phase 4UnknownMahidol University302009-06-012012-10-10
Measuring Adherence to Topical Therapy in Children With Atopic Dermatitis and the Impact of a Return Visit
tacrolimus ointment - Atopic Dermatitis
Phase 4CompletedWake Forest University302008-04-012018-08-01
Vitiligo Treated With TL01 Combined With Tacrolimus Ointment Versus Placebo
Tacrolimus ointment - Vitiligo
Phase 3CompletedOslo University Hospital2005-11-012008-12-12
Efficacy of Topical Tacrolimus in Different Subtypes With Cutaneous Lupus Erythematosus (CLE)
Tacrolimus ointment - Cutaneous Lupus Erythematosus
Phase 2CompletedHeinrich-Heine University, Duesseldorf302005-08-012007-09-10
A Multi-Center Study of Short and Long-term Use of Protopic Ointment in Patients With Atopic Dermatitis
Protopic, Corticosteroid, placebo - Dermatitis, Atopic
Phase 4CompletedAstellas Pharma Inc4102004-10-012014-09-18
Study of the Safety and Efficacy of Tacrolimus Ointment in Treating Chronic Allergic Contact Dermatitis
tacrolimus ointment, placebo ointment - Dermatitis
Phase 4CompletedAstellas Pharma Inc982004-07-012014-09-18
Treatment and Control of Atopic Dermatitis With 0.03% Tacrolimus Ointment
tacrolimus ointment, Placebo ointment - Dermatitis, Atopic
Phase 3CompletedAstellas Pharma Inc2502004-06-012014-09-18
Treatment and Control of Atopic Dermatitis With 0.1% Tacrolimus Ointment
tacrolimus ointment, Placebo ointment - Dermatitis, Atopic
Phase 3CompletedAstellas Pharma Inc2262004-04-012014-09-18
Clinical Trial to Assess the Efficacy and Safety of Tacrolimus Ointment Treatment of Atopic Dermatitis in Adult Patients
tacrolimus ointment - Dermatitis, Atopic
Phase 3CompletedAstellas Pharma Inc3032004-01-012014-09-01
Study to Evaluate the Response to Treatment and Safety of 0.03% Tacrolimus (FK506) Ointment Administered in Pediatric Patients With Moderate to Severe Atopic Dermatitis
tacrolimus ointment - Dermatitis, Atopic
Phase 3CompletedAstellas Pharma Inc1662003-10-012014-09-01
Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Treating Pediatric Patients With Atopic Dermatitis
tacrolimus ointment, pimecrolimus cream - Dermatitis, Atopic
Phase 4CompletedAstellas Pharma Inc2262002-12-012014-09-18
Comparison Study Between Protopic (Tacrolimus Ointment) and Elidel (Pimecrolimus Cream) in Pediatric Patients With Mild Atopic Dermatitis
tacrolimus ointment, pimecrolimus cream - Dermatitis, Atopic
Phase 4CompletedAstellas Pharma Inc4262002-12-012014-09-18

Showing 20 of 22. Sign in to see all of them.

Conditions studied

Dermatitis, Atopic (10)  ·  Vitiligo (4)  ·  Skin Diseases (2)  ·  Adenoviridae Infections (1)  ·  Autoimmune Diseases (1)  ·  Behcet Syndrome (1)  ·  Burns (1)  ·  Corneal Diseases (1)  ·  Dermatitis (1)  ·  Eczema (1)  ·  Kaposiform Hemangioendothelioma (1)  ·  Lupus Erythematosus, Cutaneous (1)  ·  Lymphedema (1)  ·  Oral Ulcer (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)

Sponsors

Astellas Pharma Inc (10)  ·  Assiut University (2)  ·  Benha University (1)  ·  Clarteis (1)  ·  Heinrich-Heine University, Duesseldorf (1)  ·  Mahidol University (1)  ·  Odense University Hospital (1)  ·  Oslo University Hospital (1)  ·  Tanta University (1)  ·  Vanderbilt University Medical Center (1)  ·  Wake Forest University (1)  ·  West China Hospital (1)

Countries

United States (7)  ·  Italy (4)  ·  Czechia (3)  ·  Germany (3)  ·  Belgium (2)  ·  Denmark (2)  ·  Egypt (2)  ·  Finland (2)  ·  France (2)  ·  Hungary (2)  ·  Netherlands (2)  ·  Portugal (2)  ·  Spain (2)  ·  United Kingdom (2)  ·  Austria (1)

Top investigators

Annegret Kuhn, MD (1)  ·  Chanisada Wongpraparut, M.D. (1)  ·  Eli Johanne Nordal, MD (1)  ·  Steve Feldman, MD, PHD (1)  ·  Wesley Thayer, MD, PhD (1)  ·  Yi Ji (1)

Results publications

PMID 19787413, PMID 21451378, PMID 23919018, PMID 25596811, PMID 32852646, PMID 39114823

NIH funding

2004 (1), 2018 (1)